Genomic insights into intrinsic and acquired drug resistance mechanisms in Achromobacter xylosoxidans
- PMID: 25487802
- PMCID: PMC4335856
- DOI: 10.1128/AAC.04260-14
Genomic insights into intrinsic and acquired drug resistance mechanisms in Achromobacter xylosoxidans
Abstract
Achromobacter xylosoxidans is an opportunistic pathogen known to be resistant to a wide range of antibiotics; however, the knowledge about the drug resistance mechanisms is limited. We used a high-throughput sequencing approach to sequence the genomes of the A. xylosoxidans type strain ATCC 27061 and a clinical isolate, A. xylosoxidans X02736, and then we used different bioinformatics tools to analyze the drug resistance genes in these bacteria. We obtained the complete genome sequence for A. xylosoxidans ATCC 27061 and the draft sequence for X02736. We predicted a total of 50 drug resistance-associated genes in the type strain, including 5 genes for β-lactamases and 17 genes for efflux pump systems; these genes are also conserved among other A. xylosoxidans genomes. In the clinical isolate, except for the conserved resistance genes, we also identified several acquired resistance genes carried by a new transposon embedded in a novel integrative and conjugative element. Our study provides new insights into the intrinsic and acquired drug resistance mechanisms in A. xylosoxidans, which will be helpful for better understanding the physiology of A. xylosoxidans and the evolution of antibiotic resistance in this bacterium.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
Figures





Similar articles
-
Molecular characterization of IMP-type metallo-β-lactamases among multidrug-resistant Achromobacter xylosoxidans.J Antimicrob Chemother. 2012 Sep;67(9):2110-3. doi: 10.1093/jac/dks179. Epub 2012 May 10. J Antimicrob Chemother. 2012. PMID: 22577105
-
Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypes.PLoS One. 2013 Jul 22;8(7):e68484. doi: 10.1371/journal.pone.0068484. Print 2013. PLoS One. 2013. PMID: 23894309 Free PMC article.
-
Innate aminoglycoside resistance of Achromobacter xylosoxidans is due to AxyXY-OprZ, an RND-type multidrug efflux pump.Antimicrob Agents Chemother. 2013 Jan;57(1):603-5. doi: 10.1128/AAC.01243-12. Epub 2012 Oct 22. Antimicrob Agents Chemother. 2013. PMID: 23089757 Free PMC article.
-
Genome comparison analysis of molecular mechanisms of resistance to antibiotics in the Rickettsia genus.Ann N Y Acad Sci. 2005 Dec;1063:222-30. doi: 10.1196/annals.1355.035. Ann N Y Acad Sci. 2005. PMID: 16481518 Review.
-
Investigation of antibiotic resistance in the genomic era of multidrug-resistant Gram-negative bacilli, especially Enterobacteriaceae, Pseudomonas and Acinetobacter.Expert Rev Anti Infect Ther. 2013 Mar;11(3):277-96. doi: 10.1586/eri.13.1. Expert Rev Anti Infect Ther. 2013. PMID: 23458768 Review.
Cited by
-
Achromobacter Infections and Treatment Options.Antimicrob Agents Chemother. 2020 Oct 20;64(11):e01025-20. doi: 10.1128/AAC.01025-20. Print 2020 Oct 20. Antimicrob Agents Chemother. 2020. PMID: 32816734 Free PMC article. Review.
-
Identification of Virulence Factors Involved in a Murine Model of Severe Achromobacter xylosoxidans Infection.Infect Immun. 2023 Jul 18;91(7):e0003723. doi: 10.1128/iai.00037-23. Epub 2023 May 31. Infect Immun. 2023. PMID: 37255468 Free PMC article.
-
Unraveling antibiotic resistance in Achromobacter mucicolens IA strain: genomic insights, structural analysis, and prospects for targeted therapeutics.Microbiol Spectr. 2024 Oct 29;12(12):e0392623. doi: 10.1128/spectrum.03926-23. Online ahead of print. Microbiol Spectr. 2024. PMID: 39472000 Free PMC article.
-
Draft Genome Sequence of Achromobacter sp. Strain AR476-2, Isolated from a Cellulolytic Consortium.Genome Announc. 2016 Jun 23;4(3):e00587-16. doi: 10.1128/genomeA.00587-16. Genome Announc. 2016. PMID: 27340069 Free PMC article.
-
Proteomic identification of Axc, a novel beta-lactamase with carbapenemase activity in a meropenem-resistant clinical isolate of Achromobacter xylosoxidans.Sci Rep. 2018 May 25;8(1):8181. doi: 10.1038/s41598-018-26079-z. Sci Rep. 2018. PMID: 29802257 Free PMC article.
References
-
- Yabuuchi E, Kawamura Y, Kosako Y, Ezaki T. 1998. Emendation of genus Achromobacter and Achromobacter xylosoxidans (Yabuuchi and Yano) and proposal of Achromobacter ruhlandii (Packer and Vishniac) comb. nov., Achromobacter piechaudii (Kiredjian et al.) comb. nov., and Achromobacter xylosoxidans subsp. denitrificans (Rüger and Tan) comb. nov. Microbiol Immunol 42:429–438. doi:10.1111/j.1348-0421.1998.tb02306.x. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases